FDA authorizes Ito Invivyd’s pemivibart (Pemgarda), insights on Sofosbuvir levels in pregnant women, the effectiveness of fidaxomicin vs vancomycin for CDI treatment, and more this week from Contagion.
The Latest in Clostridioides difficile Research and News
C difficile, Antimicrobials, and the Patients Most Affected
Oral Vancomycin Reduces CDI by 64% in Stem Cell Transplant Patients
Top 5 Infectious Disease News Stories Week of November 8-15
Head-to-Head Comparison of Treatments for Recurrent C difficile Infection
Top 5 Infectious Disease New Stories Week of November 2-8